The DTx market is estimated to be worth between 7 and 9 billion US dollars in the next 5 to 7 years and Prescription Digital Therapeutics [PDT] is expected  to be the future of the DTx industry, representing 57% of total DTx investment in 2020. What have been the most remarkable investments and partnerships in the DTx industry this past year? Are PDT products the future of the whole digital health industry? What are the business models that will stick in the DTx industry? In this meeting we will review the evolution of this market in the last year, the landscape of companies, recent deals and partnerships and future prospects for 2021 and beyond.